HologicHOLXEarnings & Financial Report
Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.
HOLX Q1 2026 Key Financial Metrics
Revenue
$1.0B
Gross Profit
$586.4M
Operating Profit
$237.0M
Net Profit
$179.1M
Gross Margin
56.0%
Operating Margin
22.6%
Net Margin
17.1%
YoY Growth
2.5%
EPS
$0.79
Financial Flow
Hologic Q1 2026 Financial Summary
Hologic reported revenue of $1.0B for Q1 2026, with a net profit of $179.1M (17.1% margin). Cost of goods sold was $461.4M, operating expenses totaled $349.4M.
Key Financial Metrics
| Total Revenue | $1.0B |
|---|---|
| Net Profit | $179.1M |
| Gross Margin | 56.0% |
| Operating Margin | 22.6% |
| Report Period | Q1 2026 |
Hologic Annual Revenue by Year
Hologic annual revenue history includes year-by-year totals (for example, 2025 revenue was $4.1B).
| Year | Annual Revenue |
|---|---|
| 2025 | $4.1B |
| 2024 | $4.0B |
| 2022 | $4.5B |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.02B | $1.01B | $988.0M | $1.02B | $1.01B | $1.02B | $1.05B | $1.05B |
| YoY Growth | N/A | -1.5% | 4.5% | 0.9% | -1.2% | 1.2% | 6.2% | 2.5% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $8.71B | $8.89B | $9.16B | $8.73B | $8.55B | $8.81B | $9.01B | $9.18B |
| Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | $4.84B | $4.95B | $5.13B | $4.77B | $4.62B | $4.84B | $5.05B | $5.25B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $292.4M | $405.8M | $367.0M | $189.3M | $169.4M | $343.3M | $355.1M | $229.9M |
Other Health Care Companies
ABT
Abbott Laboratories
Revenue
$11.4B
Net Profit
$1.6B
BAX
Baxter International
Revenue
$3.0B
Net Profit
$-1.1B
BDX
Becton Dickinson
Revenue
$5.3B
Net Profit
$382.0M
BSX
Boston Scientific
Revenue
$5.3B
Net Profit
$670.0M
DXCM
Dexcom
Revenue
$1.3B
Net Profit
$267.3M
EW
Edwards Lifesciences
Revenue
$1.6B
Net Profit
$291.1M
GEHC
GE HealthCare
Revenue
$5.7B
Net Profit
$588.0M
IDXX
Idexx Laboratories
Revenue
$1.1B
Net Profit
$274.6M
PODD
Insulet Corporation
Revenue
$783.7M
Net Profit
$101.6M
ISRG
Intuitive Surgical
Revenue
$2.9B
Net Profit
$794.8M